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Aim: To investigate the diagnostic value of ischemia-modified albumin (IMA) in the diagnosis of patients with aortic aneurysm.
Materials and methods: The study group consisted of 98 patients who presented to our university hospital emergency department with
aortic pathology and were definitively diagnosed using spiral tomography. The control group consisted of 101 healthy individuals with
similar demographic characteristics.
Results: Mean IMA values were 0.89 ± 0.21 absorbance units (ABSU) in the aortic aneurysm group (P < 0.001), 0.70 ± 0.12 ABSU in
the aortic dissection group (P < 0.001), 0.98 ± 0.23 ABSU in the aneurysm and dissection group (P < 0.001), 0.84 ± 0.16 ABSU in the
aneurysm and rupture group (P < 0.001), and 0.87 ± 0.27 ABSU in the aneurysm, dissection, and rupture group (P < 0.001). Mean IMA
value for the subjects in the control group was 0.62 ± 0.17 ABSU. All the differences between the aortic pathology groups’ IMA values
and those of the control group were statistically significant (P < 0.001).
Conclusion: On the basis of the findings from this study, serum IMA levels are higher in patients with aortic pathology compared to
healthy individuals. This finding suggests that IMA may help to diagnose aortic pathology, but it requires confirmation by additional
clinical studies.
Key words: Ischemia-modified albumin, aortic aneurysm, aortic dissection, aortic rupture

1. Introduction
Aortic pathologies such as aortic aneurysm, dissection,
and rupture are emergent vascular conditions. Aneurysms
sometimes require emergency surgery because of rupture
risk. The risk of rupture is related to aneurysm size and
increases with a size of 5.5 cm and above (1).
There are significant difficulties in the diagnosis of
patients with aortic aneurysm or dissection in emergency
practice. There is, as of yet, no biochemical marker suitable
for use in the diagnosis of patients with aortic aneurysm.
In aortic dissection, the arteries emerging from the aorta
may be partly or completely obstructed. Total or partial
vascular obstruction may be seen with the spread of
hematoma. This can also affect the coronary arteries.
Vascular obstruction creates ischemia in the region
nourished by blocked vessels. The resulting ischemia may
be expected to cause a rise in ischemic parameters in the
body (2).
Recently, the most frequently investigated marker for
use in such pathology is a D-dimer measurement. Studies
* Correspondence: umuteryigitacil@gmail.com
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have shown that aortic dissection increases D-dimer levels
by triggering a series of hematological reactions involving
vascular tissue and including the extrinsic pathway of the
coagulation chain (3,4).
Ischemia-modified albumin (IMA) is a marker that
has recently been much investigated and shown in studies
to increase in acute ischemic conditions. Albumin’s metalbinding capacity in the N-terminal is reduced under acute
ischemic conditions, and a metabolic protein forms. This
alteration in metal-binding capacity can be measured and
is known as IMA.
The literature contains only one study of IMA values
in aortic pathology. The present study, a pioneering one
from that perspective, compared IMA levels determined in
aortic aneurysm, dissection, or rupture patients with those
in healthy individuals. The objective was to determine,
from the results obtained, whether serum IMA levels
could serve as a guide for future research in the diagnosis
of aortic pathology.
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2. Materials and methods
2.1. Patient inclusion and exclusion criteria
The study was planned as a prospective case-control
study. Patients with aortic pathology presenting to our
university hospital emergency department with suspected
aortic aneurysm, dissection, or rupture and definitively
diagnosed using spiral tomography, and patients in
whom aortic pathology was identified after coincidental
administration of spiral tomography for other reasons,
were included. The requisite approval was obtained
from the Ethics Committee of the Karadeniz Technical
University Faculty of Medicine.
The average age of the patient group was 67.91 ±
12.91 years. Patients’ demographic data, complaints,
previous diseases, and physical examination findings
were recorded on a study form. All patients enrolled were
administered 12-derivation electrocardiogram (ECG),
pulmonary imaging, and spiral tomography, and diagnosis
was confirmed. Additionally, biochemistry, hemograms,
prothrombin time/partial thromboplastin time, D-dimer
levels, and cardiac enzymes were investigated in order to
exclude other ischemic pathology, and the results were
again recorded.
Exclusion criteria were other ischemic diseases, such
as acute coronary syndrome, acute myocardial infarction,
acute ischemic cerebrovascular disease, or pulmonary
embolism (PE); an abnormal serum albumin level making
the determination of IMA levels impossible (normal
level: 3.5–5.5 mg/dL); advanced liver, kidney, or heart
insufficiency; troponin-T and ECG variations evaluated
from the point of view of nonovert acute coronary
syndrome (ACS); age of <18 years; or refusal to participate
in the study. A control group of 101 nonhospitalized
emergency department patients (mean age ± SD: 53 ± 7
years) served as a reference for biochemical parameters.
The exclusion criteria for the control group were the same
as those for the patient group.
2.2. Laboratory analysis
Blood samples were drawn on admission. Serum samples
were prepared by 15 min of centrifugation at 3000
rpm. Specimens to be used for measuring IMA serum
concentrations were pipetted into Eppendorf tubes and
stored at –80 °C.
Reduced cobalt-to-albumin binding capacity (IMA
level) was analyzed using the rapid and colorimetric
method of Bar-Or et al. (5). Two hundred microliters of
patient serum was placed into glass tubes and 50 µL of 0.1%
CoCl2.6H2O (Sigma) was added. After gentle shaking, the
solution was left for 10 min in order to ensure sufficient
cobalt-albumin binding, and then 50 µL of 1.5 mg/mL
dithiothreitol (DTT) was added as a coloring agent. After
waiting 2 min, 1 mL of 0.9% NaCl was added in order to
halt the cobalt-albumin binding process. A colorimetric

control specimen was prepared for every limb ischemia
and control patient specimen. For the colorimetric control
samples, 50 µL of distilled water was substituted for 50
µL of 1.5 mg/mL DTT. Specimen absorbencies were
analyzed at 470 nm using a spectrophotometer (Shimadzu
UV1601). The color of the DTT containing specimens was
compared with that of the colorimetric control tubes. The
results were reported as absorbance units (ABSU).
2.3. Data analysis
All data were entered into SPSS 13.0 (SPSS Inc., Chicago,
IL, USA) and analyzed in the same program. Kruskal–
Wallis analysis of variance was used in group comparison
variance analysis (Mann–Whitney U test and corrected
Bonferroni test) and Friedman’s test in the analysis of
changes in IMA levels (Wilcoxon test and corrected
Bonferroni test). Means are shown as mean ± standard
deviation. Receiver operating characteristic (ROC) curve
analysis was performed to determine sensitivity and
specificity of cut-off values for all patients. Statistical
significance was set at P < 0.05.
3. Results
3.1. Patients’ demographic characteristics
There were 199 individuals included in the study; 98
constituted the patient group with aortic pathology and 101
the healthy control group. Demographic characteristics for
the patient and control groups are shown in Table 1.
The most common complaint at presentation was chest
pain, in 64 (65.3%) patients. Other complaints, in order of
frequency, were abdominal pain in 48 (49%), back pain in
41 (41.8%), lower back pain in 29 (29.6%), dyspnea in 32
(32.7%), syncope in 17 (17.3), palpable pulsatile mass in 5
(5.1%), and hematuria in 4 (4.1%) (Table 1).
Looking at the diseases in the patients’ histories
that might have led to aortic pathology, hypertension
was observed in the histories of 89 (90.8%) patients.
Hypertension was the most important risk factor for aortic
aneurysm and dissection. Cigarette use was also observed
in 24 (24.5%) of the patient group, all of these patients
being male. Four (4.1%) members of the patient group had
no previous complaints or diseases. Diabetes, bronchitis,
benign prostate hypertrophy, and hyperthyroid were
present in the histories of 36 (36.7%) patients (Table 1).
3.2. Patients’ IMA values
The mean IMA value in the aortic aneurysm group was
0.89 ± 0.21, while it was 0.70 ± 0.13 ABSU in the aortic
dissection group, 0.98 ± 0.24 ABSU in the aneurysm and
dissection group, 0.84 ± 0.17 ABSU in the aneurysm and
rupture group, and 0.87 ± 0.28 ABSU in the aneurysm,
dissection, and rupture group. Mean IMA level for all
aortic pathology was 0.88 ± 0.21 ABSU. Mean IMA levels
in the control group were 0.62 ± 0.18 ABSU. All differences
between the aortic pathology groups’ IMA values and
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Table 1. Patient and control group demographic characteristics.
Variables

Control group (n = 101)

Patient group (n = 98)

Sex
Male, n (%)
Female, n (%)
Presentation complaints, n (%)

78 (77.3)
23 (22.7)

61 (62.3)
37 (37.7)
64 (65.3)
48 (49)
41 (41.8)
29 (29.6)
32 (32.7)
17 (17.3)
4 (4.1)
5 (5.1)

Chest pain
Abdominal pain
Back pain
Lower back pain
Dyspnea
Hematuria
Syncope
Pulsatile mass
Past history characteristics, n (%)

89 (90.8)
24 (24.5)
4 (4.5)
36 (36.7)

Hypertension
Cigarettes
None
Other

those of the control group were statistically significant (P <
0.001). Mean IMA levels in aortic pathology are compared
individually with the control group in Table 2 and Figure 1.
The prognostic value of serum IMA levels was
evaluated with the use of a ROC curve (Figure 2). The area
under the ROC curve was obtained as 0.80 ± 0.03 (95%
CI: 0.73–0.85). The optimum cut-off point maximizing
sensitivity and specificity was 0.69 ABSU, with a sensitivity
of 84.7% and a specificity of 60.4%.
The patient group’s IMA values were statistically
significantly higher compared to those of the control group
(P < 0.001). Further examination of the patient group’s
IMA results showed the highest level in the combined
aortic aneurysm and dissection group. However, the
differences in IMA results among the aortic pathology
subgroups were not statistically significant (P = 0.126).

4. Discussion
There are significant difficulties in the diagnosis of patients
with aortic aneurysm or dissection in emergency practice.
In differential diagnosis, laboratory tests for diagnostic
purposes may provide useful clues regarding the presence
of aortic regurgitation, aortic stenosis, myocardial infarct,
myocarditis, pericarditis, cardiac tamponade, pulmonary
embolism, pancreatitis, gastroenteritis, hernias, pleural
effusion, thoracic outlet syndrome, myopathies, and
mechanical back aches. In laboratory tests run for this
purpose, there may be a rise in leukocyte numbers; elevated
blood urea nitrogen and creatinine; a rise in troponin and
creatinine kinase; the presence of hematuria, oliguria,
or anuria; or a fall in hemoglobin level in the event of
leakage from a blood vessel. In addition, D-dimer, which
has recently been investigated in a great many studies,

Table 2. Comparison of patient and control group IMA values.

n (number)
IMA
(mean ± SD, ABSU)
P*

AA

AD

AA + AD

AA + AR

AA + AD + AR

Average aortic
pathology

Control group

49

7

13

15

14

98

101

0.89 ±0.21

0.70 ± 0.13

0.98 ± 0.24

0.84 ± 0.17 0.87 ± 0.28

0.88 ± 0.21

0.62 ± 0.18

0.001

0.001

0.001

0.001

0.001

0.001

AA: Aortic aneurysm, AD: aortic dissection; AR: aortic rupture.
*: Statistical significance was found when all subgroups were compared with the control group (P = 0.001). No statistical difference was
found when subgroups were compared among themselves (P = 0.126).
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Figure 1. Comparisons of IMA levels from individual aortic
pathology and the control group. AA: Aortic aneurysm, AD:
aortic dissection; AR: aortic rupture.

has been shown to rise particularly in aortic dissection
patients (6).
In a study by Weber et al. with patients diagnosed with
aortic dissection in the emergency department, a D-dimer
cut-off value of 0.5 μg/mL was taken and a sensitivity of
100% and a specificity of 68% were determined. D-dimer
levels were shown to rise from the moment of onset of
symptoms and a correlation was determined between
dissection course and D-dimer increase, and it was seen
that the level of patients lost in the hospital was very high
(5).
Sbarouni et al. compared patients with acute aortic
dissection and chronic aneurysm alone with a healthy
control group and determined elevated D-dimer levels. A
D-dimer cut-off value of 700 ng/mL was set and sensitivity
was determined at 94%. Patients with aneurysm and acute
aortic dissection not defined as chronic were compared
with a healthy control group in that study and plasma
brain natriuretic peptide (BNP) levels were significantly
higher compared to the control group. In contrast, it has
also been reported that, unlike BNP, D-dimer can be used
as an excluding test in the diagnosis of aortic dissection
and can also be employed in the differential diagnosis of
dissection and chronic dilatation (7).
The first 3 amino acids of human serum albumin
contain binding regions for cobalt, nickel, and copper,
and these regions are very sensitive compared with
other albumin regions (8). In acute ischemic conditions,
albumin’s metal-binding capacity in the N-terminus region
declines and a metabolic protein forms. This change can be
measured and is known as IMA. Studies have determined
a normal value for IMA of 85 U/mL (ELISA results) (4).
IMA distribution levels between races and sexes have
been investigated, and while no difference in terms of
sex has been observed, a difference between races has
been determined (blacks and Caucasians). In addition,
IMA levels can rise in some conditions (end-stage kidney
disease, certain neoplasms and liver diseases, and even
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Figure 2. ROC curve of IMA levels.

in marathon runners) (9). A scan of the literature shows
that elevated IMA levels have been reported in such acute
ischemic conditions as cerebral ischemia, myocardial
ischemia, mesenteric ischemia, muscular ischemia, and
pulmonary ischemia, for which reason it has been thought
that IMA can be used as a diagnostic marker (10–12).
IMA has been investigated for use in the diagnosis
of several diseases. IMA measurement is recommended
in the diagnosis of myocardial ischemia in patients with
acute chest pain. One broad study determined that IMA
had a high negative predictive value of 90% in excluding
acute coronary syndrome in patients presenting to
the emergency department with chest pain, and that
the negative predictive value rose to 97.1% when
evaluated together with negative cardiac troponins and
nondiagnostic ECG results (12).
Bar-Or et al. determined by angiography that IMA
concentrations in the blood of patients developing
temporary ischemia began rising within a few minutes,
and that blood IMA concentrations began decreasing
to the values found in individuals with no ischemia
approximately 6 h after reperfusion with angioplasty (13).
Turedi et al. concluded that IMA can be an alternative
marker in excluding a diagnosis of PE. That study
examined IMA levels in 30 subjects diagnosed with PE
using spiral computerized tomographic angiography and
30 healthy volunteers. IMA levels were significantly higher
in the PE group compared to the healthy group (14). In
another study, D-dimer was compared with IMA. That
study consisted of 130 patients with suspected PE and
59 healthy controls, and IMA sensitivity in the diagnosis
of PE was 93%, with specificity of 75%. D-dimer was
determined to be 98.9% sensitive and 62.7% specific (8).
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These studies suggest that IMA can be an assistant marker
in the exclusion of PE. The rise in IMA level was attributed
to direct tissue hypoxia-induced ischemia, the formation
of infarct tissue, and especially tissue hypoxia arising
following massive embolism-associated hypotension (14).
In another study, IMA levels in patients with mesenteric
ischemia were significantly higher compared to those of
the control group. The elevated IMA here was ascribed to
ischemia developing as a result of cytosis (15).
Aortic dissection and ruptures can lead to a direct
increase in IMA levels. IMA can also rise in connection with
an endothelial response to aneurysmatic developments.
Endothelial tissue releases vasodilator substances such
as prostaglandin I2, nitric oxide, and prostaglandin E
for the establishment of hemodynamics and vein tonus
regulation (16). However, as the secretion of vasodilator
substances declines because of the damaged endothelium,
that of vasoconstrictor substances such as endothelin and
thrombocyte-associated growth factor rises. Vasospasm
occurs as a result, and there is a decrease in blood flow to
many organs of the body. In addition, the manufacture of
anticoagulant substances decreases as a result of endothelial
damage and thrombocyte aggregation, and clotting takes
place in the damaged endothelial region. Vasospasm
and thrombocyte aggregation take place as a result of
the release of the activated thrombocytes, thromboxane
A2, and serotonin. This further increases the endothelial
damage, and a vicious circle develops with the release of
mitogen substances from the damaged endothelium. The
vasospasm arising increases malperfusion and impairs the
blood supply in many organs. The mediator and reactive
oxygen radicals released in connection with endothelial
damage further enhance that damage and the accumulated
thrombus material makes coagulation cascade and the
associated rising biochemical parameters measurable (17).
IMA is one of the measurable markers developing
in association with this vicious circle. In the same way
that IMA can rise in any aortic pathology that may
give rise to endothelial damage, so the hypotension or
hypovolemic shock arising after dissection and rupture
will cause perfusion damage in the tissues and ischemia
development, with an associated rise in IMA.
In a paper published in 2008, Sbarouni et al. determined
similar IMA levels in acute dissection, chronic aneurysm,

and healthy control groups, with no statistically significant
difference among them. The findings in that study are
diametrically opposed to our own (18).
IMA is thus a marker whose use has been investigated in
the diagnosis of many diseases, such as coronary ischemia,
PE, deep vein thrombosis, and hemorrhagic and ischemic
stroke (19). Our study compared IMA levels in aortic
pathology with a healthy control group. We investigated
aortic pathology in 5 separate categories: aortic aneurysm,
aortic dissection, aortic aneurysm and dissection, aortic
aneurysm and rupture, and aortic aneurysm, dissection,
and rupture. All of our findings, measured both separately
and for the average of all pathologies, were significant
when compared to the healthy control group (P < 0.001).
Compared among themselves, aortic pathology had the
highest average in the aortic aneurysm and dissection
group (0.98 ABSU), while the lowest value was in the aortic
dissection alone group (0.70 ABSU). However, in terms of
IMA levels the difference among aortic pathologies was
not significant (P = 0.126). We estimated that the highest
IMA level in our study would be in the combined aortic
aneurysm, dissection, and rupture group, but this group’s
mean IMA level (0.87 ABSU) was actually in third place.
We thought this might be attributed to time of presentation
at the hospital and the patient’s existing clinical status,
blood pressure levels, and renal functions.
The main limitation in this study is that the average
age of the control group subjects was lower than that of
the patient group. That stemmed from the relatively small
number of patients meeting the inclusion criteria in the
control group compared to the older patient group. It
should also be considered that the levels of IMA are
significantly influenced by a wide range of physiological
variables. While some of these are known, not all have
yet been fully identified. We were unable to check for all
variables that could possibly influence the IMA levels.
We were unable to calculate the positive and negative
predictive values of IMA in aortic conditions because we
lacked the prevalence data for these conditions.
On the basis of the findings from this study, serum
IMA levels are higher in patients with aortic pathology
compared to healthy individuals. If confirmed by other
studies, this finding suggests that a negative IMA value
may be used to rule out aortic pathology.
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